CTSO
Cytosorbents Corp

2,146
Mkt Cap
$40.12M
Volume
157,938.00
52W High
$1.61
52W Low
$0.60
PE Ratio
-3.36
CTSO Fundamentals
Price
$0.6222
Prev Close
$0.6388
Open
$0.6515
50D MA
$0.8507
Beta
0.77
Avg. Volume
75,799.52
EPS (Annual)
-$0.3806
P/B
4.45
Rev/Employee
$238,889.40
Loading...
Loading...
News
all
press releases
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire...
PR Newswire·3d ago
News Placeholder
More News
News Placeholder
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire PRINCETON...
PR Newswire·7d ago
News Placeholder
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire PRINCETON, N.J...
PR Newswire·10d ago
News Placeholder
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire...
PR Newswire·22d ago
News Placeholder
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer In Memoriam: Dr. Robert Hawes Bartlett...
PR Newswire·24d ago
News Placeholder
CytoSorbents reported strong Q4 results, says D. Boral Capital
CytoSorbents reported strong Q4 results, says D. Boral Capital...
Yahoo! Finance: News·11mo ago
News Placeholder
Why CytoSorbents (CTSO) Stock Is Trading Higher
CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit facility with Avenue Capital Group. read more...
Benzinga·1y ago
News Placeholder
Q4 2023 Cytosorbents Corp Earnings Call Transcript
Related Stocks: NAS:CTSO...
GuruFocus·2y ago
News Placeholder
CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript
CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript...
SeekingAlpha·2y ago
News Placeholder
Recap: CytoSorbents Q4 Earnings
read more...
Benzinga·2y ago

Latest CTSO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.